# Black Swan Pharmaceuticals, Inc. — Form D

Black Swan Pharmaceuticals, Inc. of WAKE FOREST, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-09. The offering totals $600K, of which $130K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-04-09
- Form: D
- Accession: 0001808761-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $130K
- Remaining: $470K
- Investors: 1
- Date of first sale: 2020-03-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364628

## Issuer

- Name: Black Swan Pharmaceuticals, Inc.
- CIK: 0001808761
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 9008 LAURA LAKE DRIVE, WAKE FOREST, NC, 27587
- Phone: 919-612-4363

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Om Dhingra | Director | Raleigh, NC |
| Anthony Akkari | Director | Wake Forest, NC |
| Steve Arnott | Director | Wake Forest, NC |
| Julian Arbuckle | Director | Wake Forest, NC |
| Craig Metz | Director | Wake Forest, NC |
| Craig Metz | Executive Officer | Wake Forest, NC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-09-29](https://search.stillhousedata.com/formd/0001808761-21-000001) | D | $3.0M | $1.9M |

## More

- [CIK 1808761 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1808761&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001808761-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.